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Abstract
Introduction: Cytomegalovirus (CMV) is the most common 
opportunistic agent in HIV-infected patients. It can affect the 
entire gastrointestinal tract, but frequently involves the oe-
sophagus and the colon. Case Report: We report the case of 
a 70-year-old female, ultimately diagnosed with HIV infec-
tion, whose inaugural clinical manifestation was CMV colitis 
with endoscopic findings resembling a rectal tumour in 
which initial histological evaluation was not able to provide 
a proper diagnosis. Discussion/Conclusion: Since clinical 
presentation is variable and histopathological yield without 
immunohistochemical analysis is poor, recognizing CMV in-
fection in the absence of known risk factors may be difficult. 
It is crucial to consider this entity with suspicious lesions or 
when initial evaluation, either clinical or histopathological, is 
inconclusive, thus avoiding potentially debilitating and su-
perfluous treatment or life-threatening complications.
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Resumo
Introdução: O citomegalovírus (CMV) é o agente opor-
tunista mais comum nos doentes com infeção pelo vírus 
da imunodeficiência humana (VIH). Pode afetar todo o 
trato gastrointestinal, mas frequentemente envolve o es-
ófago e o cólon. Caso Clínico: Os autores apresentam o 
caso de uma doente do sexo feminino com 70 anos, com 
diagnóstico final de infeção por VIH, cuja manifestação 
clínica inaugural foi colite a CMV, com achados endoscópi-
cos iniciais mimetizando um tumor rectal. Discussão/
Conclusão: Uma vez que a apresentação clínica é variável 
e a rentabilidade da análise histopatológica sem imuno-
histoquímica é baixa, o reconhecimento da infeção por 
CMV na ausência de fatores de risco pode ser difícil. É cru-
cial considerar esta entidade perante lesões suspeitas ou 
quando a avaliação inicial, clínica ou histopatológica, for 
inconclusiva, de forma a evitar potenciais terapêuticas  
debilitantes e/ou supérfluas bem como complicações 
graves. © 2020 Sociedade Portuguesa de Gastrenterologia
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Introduction
Cytomegalovirus (CMV) is the most common oppor-
tunistic agent in HIV (human immunodeficiency virus)-
infected patients and in up to 25% of cases it provides the 
basis for the initial clinical diagnosis of acquired immu-
nodeficiency syndrome [1]. CMV can affect the entire 
gastrointestinal tract, but frequently involves the oe-
sophagus and the colon [2]. In fact, colitis is the main 
extraocular manifestation of CMV disease in HIV-in-
fected patients [3]. It is always important to be aware of 
this entity and diagnose it promptly, as life-threatening 
complications can occur, such as colonic perforation or 
gastrointestinal tract bleeding [4]. However, CMV infec-
tion diagnosis can be difficult, mainly if no risk factors 
are suspected (e.g., HIV infection, prolonged immuno-
suppression) or if its clinical suspicion was not raised for 
pathologists.
Case Report
Here we present the case of a 70-year-old, melanodermic, fe-
male patient who is a native of Cape Verde but has been resident 
in Portugal since 1997. She had previous history of arterial hy-
pertension, medicated with lisinopril and amlodipine. The pa-
tient was referred from the Surgery Department because of an 
ulcerated rectal tumour with inconclusive histopathology on bi-
opsies obtained from a previous colonoscopy. She also com-
plained of anorexia and weight loss that was not quantified. The 
physical examination was unremarkable. The blood tests showed 
a microcytic and hypochromic anaemia (Hb 8.5 g/dL, MCV 72.6 
fL, MCH 24.3 pg) and elevation of C-reactive protein (39.6 
mg/L). The colonoscopy was repeated, which revealed irregular 
and ulcerated mucosa, with necrotic areas, between 10 and 18 
cm from the anal verge (Fig. 1). On hepatic flexure, we found 
another ulcerated area involving one third of the luminal cir-
cumference (Fig. 2). Based on these findings (two ulcerated seg-
ments in the colon, blood test changes, and previous inconclu-
sive biopsies), we requested CMV immunohistochemistry (IHC) 
on colonic samples, which were positive for its presence (Fig. 3). 
The patient was prescribed valganciclovir (1 g, 3 times daily) and 
was tested for HIV infection, which was also positive. When 
questioned at this stage, the patient confessed that her husband 
was diagnosed with HIV infection a few months earlier, infor-
mation that she had not previously disclosed. There was clinical 
and endoscopic improvement after the valganciclovir therapy 
(21 days). The patient was referred to an immunodeficiency con-
sultant and started a highly active antiretroviral therapy with a 
good response.
Discussion
This is a case of HIV infection with an initial clinical 
presentation of CMV colitis. In fact, the index colonos-
copy showed only an ulcerated lesion in the rectum that 
resembled a malignant tumour. Several cases of CMV 
colorectal pseudotumors are reported in the literature [1, 
5], and it is important to be aware of this condition, main-
ly in patients with risk factors associated with immuno-
suppression.
To identify CMV colitis, colonoscopy is preferred 
over flexible sigmoidoscopy, as more than one third of 
affected patients have gross disease restricted to proximal 
regions of the colon. Furthermore, it is also important to 
Fig. 1. Rectal lesion resembling a tumour. Fig. 2. Hepatic flexure lesion.
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take multiple biopsy specimens as viral inclusions are 
most often present in the endothelial cells of the deeper 
layers of the bowel wall [2]. Histopathological examina-
tion of colorectal mucosal biopsies, stained with haema-
toxylin and eosin (HE), is a specific method (92–100%) 
but often insensitive (10–87%). IHC has been found to 
be more sensitive than HE staining (78–93%) but is not 
routinely used – only if there is a clinical suspicion raised 
by the clinician [6]. Another diagnostic tool is tissue 
polymerase chain reaction (PCR), which allows for rapid 
results and compared to IHC is more sensitive, with a 
high negative predictive value [7]. In fact, the European 
Crohn’s and Colitis Organisation recommend tissue 
PCR or IHC as the methods of choice for diagnosing 
CMV colitis [8].
Concerning treatment, all patients with CMV gastro-
intestinal disease should receive induction therapy with 
an antiviral agent for 3–6 weeks or until signs and symp-
toms have resolved. The options are ganciclovir, foscar-
net (both intravenous), or oral valganciclovir (if the pa-
tient can absorb and tolerate oral therapy and/or in mild 
disease). Antiretroviral therapy should be initiated as 
soon as CMV retinitis has been excluded and the patient 
can tolerate oral medication. If the patient is already on 
antiretroviral therapy, this should be continued. Chronic 
maintenance therapy is not recommended for CMV gas-
trointestinal disease unless there is concurrent retinitis or 
recurrent gastrointestinal disease after induction therapy 
has been discontinued [9].
Thus, this case illustrates the importance of consider-
ing CMV infection when we face colorectal lesions that 
are suspicious or when the initial diagnosis (clinical or 
pathological) is not conclusive.
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Fig. 3. a HE, mixed inflammatory infiltrate without architectural distortion and with rare crypt abscesses. b IHC, 
positive for CMV infection.
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